{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:24:50Z","timestamp":1793949890728,"version":"4.8.0"},"reference-count":395,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019978","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PWRd2022-14"],"award-info":[{"award-number":["PWRd2022-14"]}],"id":[{"id":"10.13039\/501100019978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2023AAC02038,2023AAC03665"],"award-info":[{"award-number":["2023AAC02038,2023AAC03665"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["AAC03264,2024AAC03233"],"award-info":[{"award-number":["AAC03264,2024AAC03233"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2023BEG02020"],"award-info":[{"award-number":["2023BEG02020"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biomaterials.2026.124209","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:53:07Z","timestamp":1775544787000},"page":"124209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Advanced materials for non-alcoholic fatty liver disease and cardiovascular disease comorbidity therapeutics"],"prefix":"10.1016","volume":"333","author":[{"given":"Jianrong","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-0645","authenticated-orcid":false,"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6889-2592","authenticated-orcid":false,"given":"Yue","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124209_bib1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/hep4.1760","article-title":"Nonalcoholic fatty liver disease prevalence trends among adolescents and young adults in the United States, 2007\u20102016","volume":"5","author":"Arshad","year":"2021","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biomaterials.2026.124209_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/jcdd9120419","article-title":"Comprehensive review of cardiovascular disease risk in nonalcoholic fatty liver disease","volume":"9","author":"Josloff","year":"2022","journal-title":"JCDD"},{"key":"10.1016\/j.biomaterials.2026.124209_bib3","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Mahfood Haddad","year":"2017","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cld.2023.01.014","article-title":"Nonalcoholic fatty liver disease in Asia, Africa, and Middle East region","volume":"27","author":"Ong","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.biomaterials.2026.124209_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.33667\/2078-5631-2021-29-13-20","article-title":"Comorbidity of non-alcoholic fatty liver disease and cardiovascular disease: focus on ademetionine and ursodeoxycholic acid","volume":"1","author":"Polyakova","year":"2021","journal-title":"Medicinskij Alfavit"},{"key":"10.1016\/j.biomaterials.2026.124209_bib6","author":"Chen"},{"key":"10.1016\/j.biomaterials.2026.124209_bib7","article-title":"Nonalcoholic fatty liver disease: an emerging modern-day risk factor for cardiovascular disease","author":"Hassen","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.biomaterials.2026.124209_bib8","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/jcm10081569","article-title":"Interplay between heart disease and metabolic steatosis: a contemporary perspective","volume":"10","author":"Ramadan","year":"2021","journal-title":"JCM"},{"key":"10.1016\/j.biomaterials.2026.124209_bib9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2174\/1871530322666220624161712","article-title":"Microbiome medicine: microbiota in development and management of cardiovascular diseases","volume":"22","author":"Garg","year":"2022","journal-title":"EMIDDT"},{"key":"10.1016\/j.biomaterials.2026.124209_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/00033197221091317","article-title":"Atherosclerosis and non-alcoholic fatty liver disease","volume":"73","author":"Balta","year":"2022","journal-title":"Angiology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib11","volume":"46","author":"Correction","year":"2024"},{"key":"10.1016\/j.biomaterials.2026.124209_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.hco.0000133657.77024.bd","article-title":"Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations","volume":"19","author":"Molavi","year":"2004","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib13","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu","year":"2014","journal-title":"WJG"},{"key":"10.1016\/j.biomaterials.2026.124209_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-024-03889-x","article-title":"Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review","volume":"99","author":"Svobodov\u00e1","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.527059","article-title":"miRNA dysregulation in the development of non-alcoholic fatty liver disease and the related disorders type 2 diabetes mellitus and cardiovascular disease","volume":"7","author":"L\u00f3pez-Pastor","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib16","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429287057240116040703","article-title":"A review of the dual role of MicroRNA-21 in cardiovascular diseases: riskfactor or a potential therapeutic target","volume":"17","author":"Jafari-Nozad","year":"2024","journal-title":"CMP"},{"key":"10.1016\/j.biomaterials.2026.124209_bib17","doi-asserted-by":"crossref","DOI":"10.15212\/bioi-2025-0060","article-title":"MicroRNAs in liver fibrosis: unraveling intercellular crosstalk and the regulatory functions of MicroRNA-223","volume":"6","author":"Phetkong","year":"2025","journal-title":"BIOI"},{"key":"10.1016\/j.biomaterials.2026.124209_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-28032012000100015","article-title":"Metabolic syndrome and risk factors for non-alcoholic fatty liver disease","volume":"49","author":"Souza","year":"2012","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep.28953","article-title":"Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease","volume":"65","author":"Hall","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12944-016-0221-8","article-title":"Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review","volume":"15","author":"Li","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biomaterials.2026.124209_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/10641963.2024.2303999","article-title":"The positive association between the atherogenic index of plasma and the risk of new-onset hypertension: a nationwide cohort study in China","volume":"46","author":"Yuan","year":"2024","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.biomaterials.2026.124209_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/CRD.0000000000000537","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease: causation or association","volume":"32","author":"Bali","year":"2024","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010715-103209","article-title":"Nuclear receptors as therapeutic targets in liver disease: are we there yet?","volume":"56","author":"Rudraiah","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib24","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.clinthera.2021.07.013","article-title":"Emerging and established therapeutic approaches for nonalcoholic fatty liver disease","volume":"43","author":"Brown","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biomaterials.2026.124209_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.15407\/internalmed2023.02.076","article-title":"Kharkiv National Medical University, Comorbid patient: an interdisciplinary problem (literature review)","volume":"2023","author":"Kravchun","year":"2023","journal-title":"Shidnoevr. z. Vnutr. Simejnoi Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0042-1757712","article-title":"NAFLD in cardiovascular diseases: a contributor or comorbidity?","volume":"42","author":"Chen","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biomaterials.2026.124209_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41392-023-01673-4","article-title":"Gut liver brain axis in diseases: the implications for therapeutic interventions","volume":"8","author":"Yan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124209_bib28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/pharmaceutics16081076","article-title":"Recent review on biological barriers and host\u2013material interfaces in precision drug delivery: advancement in biomaterial engineering for better treatment therapies","volume":"16","author":"Deshmukh","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/btm2.10045","article-title":"Introduction to special issue on \u201cResponsive Materials and Systems: toward Smart and Precision Medications,\u201d","volume":"1","author":"Gu","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801655","article-title":"Drug delivery strategies for the treatment of metabolic diseases","volume":"8","author":"Shi","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib31","article-title":"Multifunctional nanostructures: intelligent design to overcome biological barriers","volume":"20","author":"Azizi","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124209_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200016","article-title":"Materdicine: interdiscipline of materials and medicine","volume":"1","author":"Xiang","year":"2020","journal-title":"View"},{"key":"10.1016\/j.biomaterials.2026.124209_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1494560","article-title":"Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease","volume":"15","author":"Fan","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/obr.12820","article-title":"Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome","volume":"20","author":"Lim","year":"2019","journal-title":"Obes. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib35","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1194\/jlr.R066514","article-title":"Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.biomaterials.2026.124209_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4062\/biomolther.2021.094","article-title":"Specialized proresolving mediators for therapeutic interventions targeting metabolic and inflammatory disorders","volume":"29","author":"Han","year":"2021","journal-title":"Biomolecules & Therapeutics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-physiol-021115-105305","article-title":"Systemic nutrient and stress signaling via myokines and myometabolites","volume":"78","author":"Rai","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib38","series-title":"Comprehensive Physiology","first-page":"1","article-title":"Triglyceride metabolism in the liver","author":"Alves\u2010Bezerra","year":"2017"},{"key":"10.1016\/j.biomaterials.2026.124209_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib43","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/ATVBAHA.107.147835","article-title":"Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis","volume":"27","author":"Gustafson","year":"2007","journal-title":"ATVB"},{"key":"10.1016\/j.biomaterials.2026.124209_bib44","series-title":"Comprehensive Physiology","first-page":"1051","article-title":"Role of epicardial adipose tissue in health and disease: a matter of fat?","author":"Gaborit","year":"2017"},{"key":"10.1016\/j.biomaterials.2026.124209_bib45","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.15252\/emmm.201404749","article-title":"Heart over mind: metabolic control of white adipose tissue and liver","volume":"6","author":"Nakamura","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121614","article-title":"Gut-liver axis in the progression of nonalcoholic fatty liver disease: from the microbial derivatives-centered perspective","volume":"321","author":"Luo","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MS9.0000000000002831","article-title":"Microplastics and nanoplastics: emerging threats to cardiovascular health \u2013 a comprehensive review","volume":"87","author":"Irfan","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.biomaterials.2026.124209_bib48","author":"Blencowe"},{"key":"10.1016\/j.biomaterials.2026.124209_bib49","first-page":"236","article-title":"Chitosan-stabilized selenium nanoparticles alleviate high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) by modulating the gut barrier function and microbiota","volume":"15","author":"Luo","year":"2024","journal-title":"J. Forensic Biomech."},{"key":"10.1016\/j.biomaterials.2026.124209_bib50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.34133\/research.0363","article-title":"Remodeling intestinal microbiota alleviates severe combined hyperlipidemia-induced nonalcoholic steatohepatitis and atherosclerosis in LDLR-\/- hamsters","volume":"7","author":"Miao","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.biomaterials.2026.124209_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/cvr\/cvab076","article-title":"Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis","volume":"118","author":"Liu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib52","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1002\/ptr.7198","article-title":"Recent developments in the regulation of cholesterol transport by natural molecules","volume":"35","author":"Tan","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/diseases6020034","article-title":"Epigenetic regulation of ATP-Binding cassette protein A1 (ABCA1) gene expression: a new era to alleviate atherosclerotic cardiovascular disease","volume":"6","author":"Zaiou","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.biomaterials.2026.124209_bib55","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCRESAHA.112.300626","article-title":"Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144","volume":"112","author":"Ram\u00edrez","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib56","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1160\/TH11-10-0694","article-title":"MicroRNAs regulating lipid metabolism in atherogenesis","volume":"107","author":"Rayner","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biomaterials.2026.124209_bib57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874091X01206010078","article-title":"High density lipoprotein and it's dysfunction","volume":"6","author":"Eren","year":"2012","journal-title":"TOBIOCJ"},{"key":"10.1016\/j.biomaterials.2026.124209_bib58","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.febslet.2015.02.028","article-title":"Structural stability and functional remodeling of high\u2010density lipoproteins","volume":"589","author":"Gursky","year":"2015","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.biomaterials.2026.124209_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2015.03.058","article-title":"Structural and functional changes in HDL with low grade and chronic inflammation","volume":"188","author":"O\u2019Neill","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib60","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1194\/jlr.M054635","article-title":"Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein","volume":"56","author":"Luthi","year":"2015","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.biomaterials.2026.124209_bib61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.31083\/j.rcm2203082","article-title":"Pathophysiological mechanisms and clinical evidence of relationship between nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease","volume":"22","author":"Galiero","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mrgentox.2008.09.016","article-title":"Inhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegeneration","volume":"674","author":"Gomez-Mejiba","year":"2009","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen"},{"key":"10.1016\/j.biomaterials.2026.124209_bib63","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2011.10.022","article-title":"Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?","volume":"11","author":"Costenbader","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib64","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib65","article-title":"Effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: a review","volume":"25","author":"Ebrahimian","year":"2022","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib66","first-page":"4506","article-title":"Anti-inflammatory properties of plant derived natural products \u2013 a systematic review","volume":"26","author":"Allijn","year":"2019","journal-title":"Comput. Mater. Continua (CMC)"},{"key":"10.1016\/j.biomaterials.2026.124209_bib67","first-page":"1611","article-title":"Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"22","author":"Moghtadaie","year":"2023","journal-title":"EXCLI J."},{"key":"10.1016\/j.biomaterials.2026.124209_bib68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.55730\/1300-0152.2658","article-title":"Antioxidant potential of nanomaterials","volume":"47","author":"Flores","year":"2023","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib69","article-title":"Development and optimization of novel drug delivery systems for targeted therapy: an analytical perspective","volume":"5","year":"2023","journal-title":"Ejmcm"},{"key":"10.1016\/j.biomaterials.2026.124209_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2014.00352","article-title":"Reactive oxygen species at the crossroads of inflammasome and inflammation","volume":"5","author":"Harijith","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib71","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ccell.2017.05.006","article-title":"Kupffer cell-derived tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS","volume":"31","author":"Yuan","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2026.124209_bib72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.69951\/proceedingsbookoficeonimeri.v6i-.131","article-title":"Innate immune response in non alcoholic fatty liver disease: an overview of alterations in TLR9, macrophages, and TNF\u03b1","volume":"6","author":"Supriatna","year":"2022","journal-title":"Proceedings Book of ICE on IMERI"},{"key":"10.1016\/j.biomaterials.2026.124209_bib73","author":"Dominic"},{"key":"10.1016\/j.biomaterials.2026.124209_bib74","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhazmat.2010.07.010","article-title":"Zinc oxide particles induce inflammatory responses in vascular endothelial cells via NF-\u03baB signaling","volume":"183","author":"Tsou","year":"2010","journal-title":"J. Hazard Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib76","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.3390\/cells10113164","article-title":"High-fat, western-style diet, systemic inflammation, and gut microbiota: a narrative review","volume":"10","author":"Malesza","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124209_bib77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0039-1678727","article-title":"Novel targets in the immune microenvironment of the hepatic sinusoids for treating liver diseases","volume":"39","author":"Patten","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biomaterials.2026.124209_bib78","article-title":"Single-cell spatial transcriptomics in cardiovascular development, disease, and medicine","volume":"11","author":"Han","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.biomaterials.2026.124209_bib79","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.118.033544","article-title":"Protease-activated Receptor-2 plays a critical role in vascular inflammation and atherosclerosis in apolipoprotein E\u2013Deficient mice","volume":"138","author":"Hara","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2026.124209_bib80","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2006.11059","article-title":"The relationship between inflammation and the coagulation system","author":"Choi","year":"2006","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.biomaterials.2026.124209_bib81","article-title":"Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation","volume":"20","author":"Wang","year":"2014","journal-title":"WJG"},{"key":"10.1016\/j.biomaterials.2026.124209_bib82","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124209_bib83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.molmed.2017.03.001","article-title":"Connecting the metabolic and immune responses to cancer","volume":"23","author":"Flint","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib84","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2174\/138920012803762792","article-title":"Mitochondrial dysfunction and lipid homeostasis","volume":"13","author":"Vamecq","year":"2012","journal-title":"CDM"},{"key":"10.1016\/j.biomaterials.2026.124209_bib85","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s44318-024-00037-0","article-title":"Chewing the fat for good health: ACSM3 deficiency exacerbates metabolic syndrome","volume":"43","author":"Cazarin","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.biomaterials.2026.124209_bib86","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/cells8111383","article-title":"The role of signaling pathways of inflammation and oxidative stress in development of senescence and aging phenotypes in cardiovascular disease","volume":"8","author":"Papaconstantinou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124209_bib87","doi-asserted-by":"crossref","DOI":"10.15212\/CVIA.2024.0020","article-title":"Exosomal circRNA-0008302 from adipose-derived stem cells protects against myocardial injury","volume":"9","author":"Hu","year":"2024","journal-title":"CVIA"},{"key":"10.1016\/j.biomaterials.2026.124209_bib88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.22138\/2500-0918-2022-19-2-95-108","article-title":"The perspective of using cerium oxide nanoparticles in liver diseases","volume":"19","author":"Grebnev","year":"2022","journal-title":"JUMAS"},{"key":"10.1016\/j.biomaterials.2026.124209_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-Hydroxy-2-Nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib90","doi-asserted-by":"crossref","first-page":"G298","DOI":"10.1152\/ajpgi.00135.2019","article-title":"Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats","volume":"318","author":"Turkseven","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib91","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/molecules25153469","article-title":"Protective effects of polyphenols against ischemia\/reperfusion injury","volume":"25","author":"Cebova","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2026.124209_bib92","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3390\/coatings13121981","article-title":"Strategies to enhance biomedical device performance and safety: a comprehensive review","volume":"13","author":"S\u00e1nchez-Bod\u00f3n","year":"2023","journal-title":"Coatings"},{"key":"10.1016\/j.biomaterials.2026.124209_bib93","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/plc.2024.6","article-title":"Mitochondria as a target of micro- and nanoplastic toxicity","volume":"2","author":"Y\u00f6ntem","year":"2024","journal-title":"Cambridge Prisms: Plastics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.149584","article-title":"Nanomaterials-induced toxicity on cardiac myocytes and tissues, and emerging toxicity assessment techniques","volume":"800","author":"Cheng","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.biomaterials.2026.124209_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1504718","article-title":"Editorial: role of mitochondrial stress response in metabolic health","volume":"15","author":"Pereira","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2026.124209_bib97","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7150\/ijbs.30464","article-title":"Reactive oxygen species related noncoding RNAs as regulators of cardiovascular diseases","volume":"15","author":"Dong","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib98","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"Fiorucci","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib99","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/biom14070841","article-title":"Bile acids as emerging players at the intersection of steatotic liver disease and cardiovascular diseases","volume":"14","author":"Bilson","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.biomaterials.2026.124209_bib100","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","article-title":"Role of bile acids in metabolic control","volume":"29","author":"Molinaro","year":"2018","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0735-1097(20)30729-4","article-title":"Gut microbiota and bile acids metabolism at the crossroad between cholesterol homeostasis and chronic inflammation in endothelial dysfunction and arterial stiffness","volume":"75","author":"Liu","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib103","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3389\/fimmu.2017.01159","article-title":"Fructose: a dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease","volume":"8","author":"Lambertz","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib104","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.12688\/f1000research.12449.1","article-title":"Recent advances in understanding bile acid homeostasis","volume":"6","author":"Chiang","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.biomaterials.2026.124209_bib105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","article-title":"Targeting the alternative bile acid synthetic pathway for metabolic diseases","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.biomaterials.2026.124209_bib106","doi-asserted-by":"crossref","DOI":"10.15212\/CVIA.2023.0090","article-title":"Gut microbiota and vascular diseases: an update","volume":"9","author":"Wu","year":"2024","journal-title":"CVIA"},{"key":"10.1016\/j.biomaterials.2026.124209_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101493","article-title":"Gut microbiome and bile acids in obesity-related diseases","volume":"35","author":"Li","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib108","series-title":"Bile Acids and their Receptors","first-page":"207","article-title":"Potential of intestine-selective FXR modulation for treatment of metabolic disease","author":"Van Zutphen","year":"2019"},{"key":"10.1016\/j.biomaterials.2026.124209_bib109","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","article-title":"Bile acid signaling in metabolic and inflammatory diseases and drug development","volume":"76","author":"Li","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2015.01.001","article-title":"Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids","volume":"5","author":"Ferrebee","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124209_bib111","series-title":"Bile Acids and Their Receptors","first-page":"73","article-title":"The enterokine fibroblast growth factor 15\/19 in bile acid metabolism","author":"Cariello","year":"2019"},{"key":"10.1016\/j.biomaterials.2026.124209_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120152","article-title":"Bile acids as regulatory molecules and potential targets in metabolic diseases","volume":"287","author":"Xie","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib113","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib114","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1042\/CS20241137","article-title":"Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"138","author":"Lopez-Pascual","year":"2024","journal-title":"Clinical Science"},{"key":"10.1016\/j.biomaterials.2026.124209_bib115","first-page":"172","article-title":"Focus on extracellular vesicles: development of extracellular vesicle-based therapeutic systems","volume":"17","author":"Ohno","year":"2016","journal-title":"Indian J. Manag. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib116","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pharmthera.2016.04.007","article-title":"Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis","volume":"164","author":"Sivaprakasam","year":"2016","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.biomaterials.2026.124209_bib117","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","article-title":"Gut microbiota derived metabolites in cardiovascular health and disease","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.biomaterials.2026.124209_bib118","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bpg.2013.03.006","article-title":"Function of the microbiota","volume":"27","author":"Rajili\u0107-Stojanovi\u0107","year":"2013","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13765-022-00755-1","article-title":"Effects of SCFAs and TMAO on non-alcoholic fatty liver disease indicating the therapeutic benefits of plant-based diet, and supplemental prebiotics, probiotics and synbiotics","volume":"66","author":"Vu","year":"2023","journal-title":"Appl Biol Chem"},{"key":"10.1016\/j.biomaterials.2026.124209_bib120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-food-030212-182554","article-title":"Impact of diet on human intestinal microbiota and health","volume":"5","author":"Salonen","year":"2014","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.742465","article-title":"Preclinical evidence of berberine on non-alcoholic fatty liver disease: a systematic review and meta-analysis of animal studies","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib122","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/microorganisms12081627","article-title":"The role of Akkermansia muciniphila on improving gut and metabolic health modulation: a meta-analysis of preclinical mouse model studies","volume":"12","author":"Khalili","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.biomaterials.2026.124209_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.134976","article-title":"Recent advances in understanding the effects of nanomaterials on gut microbiota","volume":"435","author":"Xie","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2026.124209_bib124","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41467-020-14323-y","article-title":"A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism","volume":"11","author":"Pradas-Juni","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124209_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108360","article-title":"Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota","volume":"80","author":"Golonka","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biomaterials.2026.124209_bib126","series-title":"Multifunctional Pharmaceutical Nanocarriers","first-page":"1","article-title":"Multifunctional pharmaceutical nanocarriers: development of the concept","author":"Torchilin","year":"2008"},{"key":"10.1016\/j.biomaterials.2026.124209_bib127","first-page":"d717","article-title":"Targeting hepatocytes for drug and gene delivery emerging novel approaches and applications","volume":"7","author":"Wu","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib128","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1166\/jnn.2021.19065","article-title":"Anti-vascular cell adhesion Molecule-1 nanosystems: a promising strategy against inflammatory based diseases","volume":"21","author":"Ailuno","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903138","article-title":"Nanodrug with ROS and pH dual\u2010sensitivity ameliorates liver fibrosis via multicellular regulation","volume":"7","author":"Lin","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib131","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1517\/17425247.2012.679261","article-title":"Novel materials which possess the ability to target liver cells","volume":"9","author":"Chen","year":"2012","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2026.124209_bib132","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.24976\/Discov.Med.202436187.142","article-title":"Tailored-biomaterials based potential strategies for cardiovascular disease","volume":"36","author":"Bhullar","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib133","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cbic.201600023","article-title":"ASGPR\u2010Mediated uptake of multivalent glycoconjugates for drug delivery in hepatocytes","volume":"17","author":"Monestier","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.biomaterials.2026.124209_bib134","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.RES.0000155722.17881.dd","article-title":"Detection of vascular adhesion Molecule-1 expression using a novel multimodal nanoparticle","volume":"96","author":"Kelly","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2008.04.001","article-title":"Materials for advanced drug delivery in the 21st century: a focus area for advanced drug delivery reviews","volume":"60","author":"Ghandehari","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib136","doi-asserted-by":"crossref","DOI":"10.15212\/AMM-2022-0046","article-title":"Mass spectrometry imaging advances and application in pharmaceutical research","volume":"1","author":"Song","year":"2022","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.biomaterials.2026.124209_bib137","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/1567201818666210708123007","article-title":"Recent advances in mesoporous silica nanoparticles for targeted DrugDelivery applications","volume":"19","author":"Abu-Dief","year":"2022","journal-title":"CDD"},{"key":"10.1016\/j.biomaterials.2026.124209_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003537","article-title":"A versatile nonviral delivery system for multiplex gene\u2010editing in the liver","volume":"32","author":"Gong","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib139","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/cen.12095","article-title":"Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives","volume":"78","author":"Woo","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.omtn.2020.03.016","article-title":"Ultrasound assisted exosomal delivery of tissue responsive mRNA for enhanced efficacy and minimized off-target effects","volume":"20","author":"Sun","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biomaterials.2026.124209_bib141","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12195-019-00573-4","article-title":"Cell subtypes within the liver microenvironment differentially interact with lipid nanoparticles","volume":"12","author":"Sago","year":"2019","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.biomaterials.2026.124209_bib142","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4155\/tde-2017-0060","article-title":"Delivering natural products and biotherapeutics to improve drug efficacy","volume":"8","author":"Obeid","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biomaterials.2026.124209_bib143","first-page":"950","article-title":"Targeting of therapeutics to the liver: liposomes and viral vectors","volume":"23","author":"Di Campli","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib144","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1166\/jbn.2023.3597","article-title":"Nanocarrier based targeting of vascular cell adhesion Molecule-1 for diagnosis and treatment of atherosclerosis: current status and future perspectives","volume":"19","author":"Wang","year":"2023","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.127296","article-title":"Biomimetic liposomes hybrid with platelet membranes for targeted therapy of atherosclerosis","volume":"408","author":"Song","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2026.124209_bib146","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2026.124209_bib147","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.2174\/1381612822666160822150243","article-title":"Targeting mitochondria in cardiovascular diseases","volume":"22","author":"Silva","year":"2016","journal-title":"CPD"},{"key":"10.1016\/j.biomaterials.2026.124209_bib148","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1021\/acs.biomac.9b00628","article-title":"Recent advances on reactive oxygen species-responsive delivery and diagnosis system","volume":"20","author":"Ye","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2026.124209_bib149","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/mp3005885","article-title":"Multifunctional gold nanoparticles for diagnosis and therapy of disease","volume":"10","author":"Mieszawska","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124209_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105348","article-title":"Ischemic microenvironment\u2010responsive therapeutics for cardiovascular diseases","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib151","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1039\/C5TB00988J","article-title":"Oligoproline-derived nanocarrier for dual stimuli-responsive gene delivery","volume":"3","author":"Gupta","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biomaterials.2026.124209_bib152","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2174\/0929866521666140626102429","article-title":"Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs","volume":"21","author":"Hu","year":"2014","journal-title":"PPL"},{"key":"10.1016\/j.biomaterials.2026.124209_bib153","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1021\/nl404816m","article-title":"Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus","volume":"14","author":"Bruckman","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2026.124209_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23336","article-title":"Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting","volume":"111","author":"Bertoni","year":"2020","journal-title":"Biopolymers"},{"key":"10.1016\/j.biomaterials.2026.124209_bib155","first-page":"378","article-title":"Silicified curcumin microspheres combats cardiovascular diseases via Nrf2\/HO-1 pathway","volume":"49","author":"Guan","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib156","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/adma.201301376","article-title":"Dual surface\u2010functionalized janus nanocomposites of Polystyrene\/Fe3 O4 @SiO2 for simultaneous tumor cell targeting and stimulus\u2010induced drug release","volume":"25","author":"Wang","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib157","article-title":"Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy","volume":"2","author":"Li","year":"2023","journal-title":"Smart Medicine"},{"key":"10.1016\/j.biomaterials.2026.124209_bib158","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1021\/acsnano.5b01433","article-title":"Nanocomposite hydrogels: 3D polymer\u2013nanoparticle synergies for On-Demand drug delivery","volume":"9","author":"Merino","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124209_bib159","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/acs.accounts.6b00536","article-title":"Designing hydrogels for On-Demand therapy","volume":"50","author":"Oliva","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.yjmcc.2018.08.026","article-title":"Matrix metalloproteinases in pro-atherosclerotic arterial remodeling","volume":"123","author":"Myasoedova","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110173","article-title":"Essential metals in health and disease","volume":"367","author":"Jomova","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biomaterials.2026.124209_bib162","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1098\/rsif.2011.0611","article-title":"Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments","volume":"9","author":"Mouri\u00f1o","year":"2012","journal-title":"J. R. Soc., Interface"},{"key":"10.1016\/j.biomaterials.2026.124209_bib163","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14797\/mdcj-15-1-62","article-title":"Gene delivery in lipid research and therapies","volume":"15","author":"De Giorgi","year":"2019","journal-title":"Methodist DeBakey Cardiovasc. J."},{"key":"10.1016\/j.biomaterials.2026.124209_bib164","article-title":"Lactate transporter MCT4 regulates the hub genes for lipid metabolism and inflammation to attenuate intracellular lipid accumulation in non-alcoholic fatty liver disease","volume":"12","author":"Gou","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.biomaterials.2026.124209_bib165","first-page":"273","volume":"26","author":"Zhang","year":"2025"},{"key":"10.1016\/j.biomaterials.2026.124209_bib166","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/304\/1\/012089","article-title":"Kinetic behaviour of nanoparticles across the biological physiology","volume":"304","author":"Emond","year":"2011","journal-title":"J. Phys., Conf. Ser."},{"key":"10.1016\/j.biomaterials.2026.124209_bib167","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the treatment of liver fibrosis","volume":"12","author":"Poilil Surendran","year":"2017","journal-title":"IJN"},{"key":"10.1016\/j.biomaterials.2026.124209_bib168","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.copbio.2020.02.013","article-title":"Systems metabolomics: from metabolomic snapshots to design principles","volume":"63","author":"Damiani","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1278243","article-title":"Editorial: construction of smart materials for biomedical application","volume":"11","author":"Chen","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib170","volume":"2008","author":"Cho","year":"2008"},{"key":"10.1016\/j.biomaterials.2026.124209_bib171","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6633\/abfaad","article-title":"Multi-level aggregation of conjugated small molecules and polymers: from morphology control to physical insights","volume":"84","author":"Li","year":"2021","journal-title":"Rep. Prog. Phys."},{"key":"10.1016\/j.biomaterials.2026.124209_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.649048","article-title":"Reactive oxygen species responsive polymers for drug delivery systems","volume":"9","author":"Gao","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.biomaterials.2026.124209_bib173","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/antiox11010091","article-title":"Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease","volume":"11","author":"Ma","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biomaterials.2026.124209_bib174","first-page":"58018","article-title":"Full active nanoplatform restores ROS homeostasis for synergistic therapy of fatty liver disease via dual endogenous-exogenous pathways","volume":"17","author":"Lin","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124209_bib175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42550-y","article-title":"Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload","volume":"13","author":"Bashandy","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124209_bib176","article-title":"Potentialities of nanomaterials for the management and treatment of metabolic syndrome: a new insight","volume":"13","author":"Adetunji","year":"2022","journal-title":"Mater. Today Adv."},{"key":"10.1016\/j.biomaterials.2026.124209_bib177","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria\u2010targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib178","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1111\/febs.15424","article-title":"Mitochondrial light switches: optogenetic approaches to control metabolism","volume":"287","author":"Berry","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.biomaterials.2026.124209_bib179","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.sjbs.2020.07.030","article-title":"Emerging insights into mitochondria-specific targeting and drug delivering strategies: recent milestones and therapeutic implications","volume":"27","author":"Dhanasekaran","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41401-021-00681-w","article-title":"Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress","volume":"43","author":"Zhao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biomaterials.2026.124209_bib181","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/ab500171a","article-title":"Bioinspired nanotheranostic agents: synthesis, surface functionalization, and antioxidant potential","volume":"1","author":"Bhaumik","year":"2015","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2026.124209_bib182","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"WJG"},{"key":"10.1016\/j.biomaterials.2026.124209_bib183","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/anie.201915826","article-title":"Smart design of nanomaterials for mitochondria\u2010targeted nanotherapeutics","volume":"60","author":"Liew","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2026.124209_bib184","doi-asserted-by":"crossref","first-page":"29902","DOI":"10.1021\/acsami.4c04952","article-title":"Mito-specific Nutri-Hijacker synergizing mitochondrial metabolism and glycolysis intervention for enhanced antitumor bioenergetic therapy","volume":"16","author":"Yang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124209_bib185","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.112.268946","article-title":"Mitochondrial control of cellular life, stress, and death","volume":"111","author":"Galluzzi","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib186","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/pharmaceutics12111122","article-title":"Mitochondria-targeted drug delivery in cardiovascular disease: a long road to nano-cardio medicine","volume":"12","author":"Forini","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib187","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41392-021-00645-w","article-title":"Spatiotemporal control of CRISPR\/Cas9 gene editing","volume":"6","author":"Zhuo","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124209_bib188","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70099","article-title":"CRISPR technology in disease management: an updated review of clinical translation and therapeutic potential","volume":"58","author":"Far","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biomaterials.2026.124209_bib189","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.tibtech.2023.06.005","article-title":"Enhancing CRISPR\/cas systems with nanotechnology","volume":"41","author":"Chowdhry","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2052-8426-2-5","article-title":"Harnessing RNAi nanomedicine for precision therapy","volume":"2","author":"Peer","year":"2014","journal-title":"Mol and Cell Ther"},{"key":"10.1016\/j.biomaterials.2026.124209_bib191","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MOL.0000000000000186","article-title":"Regulation of lipid metabolism by microRNAs","volume":"26","author":"Tate","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib192","first-page":"7855","article-title":"Recent developments in delivery of MicroRNAs utilizing nanosystems for metabolic syndrome therapy","volume":"22","author":"Li","year":"2021","journal-title":"Indian J. Manag. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib193","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart","volume":"73","author":"Stahl","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib194","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/antiox5020015","article-title":"Antioxidant cerium oxide nanoparticles in biology and medicine","volume":"5","author":"Nelson","year":"2016","journal-title":"Antioxidants"},{"key":"10.1016\/j.biomaterials.2026.124209_bib195","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.nano.2013.01.012","article-title":"Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application","volume":"9","author":"Lehner","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib196","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1096\/fj.15-275404","article-title":"Mitochondria\u2010targeted antioxidants","volume":"29","author":"Oyewole","year":"2015","journal-title":"FASEB j."},{"key":"10.1016\/j.biomaterials.2026.124209_bib197","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/nu13061881","article-title":"Natural products in the prevention of metabolic diseases: lessons learned from the 20th KAST frontier scientists workshop","volume":"13","author":"Baek","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biomaterials.2026.124209_bib198","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00018-024-05199-y","article-title":"The impact of nanomaterials on autophagy across health and disease conditions","volume":"81","author":"Florance","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib199","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/ptr.7101","article-title":"Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2\u2010CREB\u2010SIRT1 axis","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.livres.2020.02.004","article-title":"Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease","volume":"4","author":"Chen","year":"2020","journal-title":"Liver Research"},{"key":"10.1016\/j.biomaterials.2026.124209_bib201","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/nu12010130","article-title":"Health-promoting properties of proanthocyanidins for intestinal dysfunction","volume":"12","author":"Gonz\u00e1lez-Quilen","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biomaterials.2026.124209_bib202","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2018.03.001","article-title":"Macrophage-targeted therapeutics for metabolic disease","volume":"39","author":"Peterson","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","article-title":"Preclinical and clinical advances of GalNAc-Decorated nucleic acid therapeutics","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biomaterials.2026.124209_bib204","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1021\/acs.chemmater.6b05357","article-title":"High-density lipoprotein-like magnetic nanostructures (HDL-MNS): theranostic agents for cardiovascular disease","volume":"29","author":"Nandwana","year":"2017","journal-title":"Chem. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2018.07.002","article-title":"Brown adipose tissue and lipid metabolism: new strategies for identification of activators and biomarkers with clinical potential","volume":"192","author":"Xiang","year":"2018","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.biomaterials.2026.124209_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102569","article-title":"Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress","volume":"59","author":"Abulikemu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib207","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900632","article-title":"Tailoring biomaterials for metabolic diseases","volume":"8","author":"Gu","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114108","article-title":"Technology insight: plant-derived vesicles\u2014How far from the clinical biotherapeutics and therapeutic drug carriers?","volume":"182","author":"Cong","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib209","doi-asserted-by":"crossref","DOI":"10.15212\/bioi-2025-0122","article-title":"Exogenous extracellular vesicles as emerging platforms in translational medicine","volume":"6","author":"Bai","year":"2025","journal-title":"BIOI"},{"key":"10.1016\/j.biomaterials.2026.124209_bib210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21775\/cimb.022.041","article-title":"Liver X receptors and their agonists: targeting for cholesterol homeostasis and cardiovascular diseases","author":"Ma","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543776.2020.1703952","article-title":"Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)","volume":"30","author":"Takada","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biomaterials.2026.124209_bib212","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2021.03.022","article-title":"Browning white adipose tissue using adipose stromal cell-targeted resveratrol-loaded nanoparticles for combating obesity","volume":"333","author":"Zu","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124209_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2020.104501","article-title":"Recent advances in natural polymer-based drug delivery systems","volume":"148","author":"Tong","year":"2020","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.biomaterials.2026.124209_bib214","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.2174\/1381612826666200610111013","article-title":"Applications of nanocarriers as drug delivery vehicles for active phytoconstituents","volume":"26","author":"Ng","year":"2020","journal-title":"CPD"},{"key":"10.1016\/j.biomaterials.2026.124209_bib215","doi-asserted-by":"crossref","DOI":"10.4028\/b-qT7ius","article-title":"siRNA\/CS\u2010PLGA nanoparticle system targeting knockdown intestinal SOAT2 reduced intestinal lipid uptake and alleviated obesity","volume":"11","author":"Liang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22164","article-title":"The current perspective and opportunities of small nucleic acid\u2010based therapeutics","volume":"85","author":"Chen","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib217","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11883-010-0106-7","article-title":"Insights into atherosclerosis using nanotechnology","volume":"12","author":"Jayagopal","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.biomaterials.2026.124209_bib218","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2533\/chimia.2022.236","article-title":"Tailoring design of nanomaterials and systems to individualize patient treatments","volume":"76","author":"Buljan","year":"2022","journal-title":"Chimia"},{"key":"10.1016\/j.biomaterials.2026.124209_bib219","article-title":"Properties and application of carbon quantum dots (CQDs) in biosensors for disease detection: a comprehensive review","volume":"80","author":"Pourmadadi","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib220","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.7150\/ijbs.33837","article-title":"Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer","volume":"15","author":"Cheng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib221","article-title":"Reprogramming macrophages to treat liver diseases","author":"Sim\u00f3n-Codina","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib222","doi-asserted-by":"crossref","first-page":"275","DOI":"10.34133\/research.0275","article-title":"Protective and adverse roles of DDX3X in different cell types in nonalcoholic steatohepatitis progression","volume":"6","author":"Yang","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.biomaterials.2026.124209_bib223","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70012","article-title":"Targeting regulation of macrophage to treat metabolic disease: role of phytochemicals","volume":"58","author":"Ye","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biomaterials.2026.124209_bib224","doi-asserted-by":"crossref","DOI":"10.1515\/ntrev-2015-0057","article-title":"Smart mesoporous silica nanoparticles for controlled-release drug delivery","volume":"5","author":"Karimi","year":"2016","journal-title":"Nanotechnol. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib225","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2174\/1568026614666140329232252","article-title":"Expanding the therapeutic potential of statins by means of nanotechnology enabled drug delivery systems","volume":"14","author":"Romana","year":"2014","journal-title":"CTMC"},{"key":"10.1016\/j.biomaterials.2026.124209_bib226","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.7150\/thno.64229","article-title":"Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment","volume":"11","author":"Bu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40820-025-01665-9","article-title":"Developing mRNA nanomedicines with advanced targeting functions","volume":"17","author":"Wang","year":"2025","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.biomaterials.2026.124209_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107083","article-title":"Metabolic disorders affecting the liver and heart: therapeutic efficacy of miRNA-based therapies?","volume":"201","author":"La Sala","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib229","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3390\/biomedicines12122683","article-title":"Exosomes as regulators of macrophages in cardiovascular diseases","volume":"12","author":"Soriano-Cruz","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.biomaterials.2026.124209_bib230","first-page":"345","article-title":"3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and angiogenesis","volume":"45","author":"Dutta","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib231","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.copbio.2012.05.007","article-title":"Material strategies for creating artificial cell-instructive niches","volume":"23","author":"Edalat","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib232","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1021\/acs.nanolett.7b03405","article-title":"Remote manipulation of ligand nano-oscillations regulates adhesion and polarization of macrophages in vivo","volume":"17","author":"Kang","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2026.124209_bib233","article-title":"Remote switching of elastic movement of decorated ligand nanostructures controls the adhesion\u2010regulated polarization of host macrophages","volume":"31","author":"Thangam","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib234","doi-asserted-by":"crossref","first-page":"20908","DOI":"10.18632\/oncotarget.24556","article-title":"Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages","volume":"9","author":"De Groot","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2026.124209_bib235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3724\/zdxbyxb-2022-0047","article-title":"Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy","volume":"51","author":"Ye","year":"2022","journal-title":"J. Zhejiang Univ. (Sci. Ed.)"},{"key":"10.1016\/j.biomaterials.2026.124209_bib236","doi-asserted-by":"crossref","first-page":"C481","DOI":"10.1152\/ajpcell.00147.2020","article-title":"Extracellular matrix dynamics in vascular remodeling","volume":"319","author":"Ma","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib237","first-page":"1159","article-title":"Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases","year":"2000","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111160","article-title":"Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis","volume":"116","author":"Hussein","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.biomaterials.2026.124209_bib239","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nmat3922","article-title":"Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition","volume":"13","author":"Purcell","year":"2014","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib240","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/pi.5170","article-title":"Recent advances in magnetic hydrogels","volume":"65","author":"Zhang","year":"2016","journal-title":"Polym. Int."},{"key":"10.1016\/j.biomaterials.2026.124209_bib241","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1049\/bsbt.2019.0009","article-title":"Bio\u2010inspired nanofunctionalisation of biomaterial surfaces: a review","volume":"5","author":"Xie","year":"2019","journal-title":"Biosurface and Biotribology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib242","doi-asserted-by":"crossref","first-page":"17933","DOI":"10.1073\/pnas.1001192107","article-title":"Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones","volume":"107","author":"Yuen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biomaterials.2026.124209_bib243","series-title":"Proceedings of 2011 International Conference on Computer Science and Network Technology","first-page":"2716","article-title":"Research on the bio-safety of nanomaterials","author":"Cheng","year":"2011"},{"key":"10.1016\/j.biomaterials.2026.124209_bib244","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.cca.2010.08.016","article-title":"Silver nanoparticle applications and human health","volume":"411","author":"Ahamed","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biomaterials.2026.124209_bib245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.682284","article-title":"The advancing of selenium nanoparticles against infectious diseases","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib246","doi-asserted-by":"crossref","DOI":"10.1155\/mi\/1153091","article-title":"Role of dendritic cells in mediating the effect of growth differentiation factor 15 on nonalcoholic fatty liver disease: insights from causal inference and single-cell profiling","volume":"2025","author":"Yao","year":"2025","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.biomaterials.2026.124209_bib247","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.191479","article-title":"PAD4+ neutrophils promote hepatic stellate cell activation and accelerate MASH fibrosis progression viaNET-DNA\/TAOK1\/MAPK pathways","volume":"11","author":"Shen","year":"2026","journal-title":"JCI Insight"},{"key":"10.1016\/j.biomaterials.2026.124209_bib248","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1051076","article-title":"Crucial role of T cells in NAFLD-related disease: a review and prospect","volume":"13","author":"Mao","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib249","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.biomaterials.2026.124209_bib250","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.biomaterials.2026.124209_bib251","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4254\/wjh.v6.i3.114","article-title":"Thyroid hormone analogues and derivatives: actions in fatty liver","volume":"6","author":"Coppola","year":"2014","journal-title":"WJH"},{"key":"10.1016\/j.biomaterials.2026.124209_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116294","article-title":"Lipid metabolism: a molecular switch to control inflammation","volume":"173","author":"Cheng","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib253","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/10837450902922736","article-title":"Drug delivery technologies for chronotherapeutic applications","volume":"14","author":"Khan","year":"2009","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100030","article-title":"Quercetin-encapsulated GelMa hydrogel microneedle reduces oxidative stress and facilitates wound healing","volume":"3","author":"Yi","year":"2024","journal-title":"Nano TransMed"},{"key":"10.1016\/j.biomaterials.2026.124209_bib255","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.biomaterials.2026.124209_bib256","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/S0954422419000210","article-title":"Crosstalk between mitochondrial metabolism and oxidoreductive homeostasis: a new perspective for understanding the effects of bioactive dietary compounds","volume":"33","author":"Di Giacomo","year":"2020","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib257","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41467-023-38165-6","article-title":"Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease","volume":"14","author":"Zeng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124209_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215540","article-title":"Advanced nanomaterials for enhanced immunotherapy via metabolic regulation","volume":"500","author":"Li","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib260","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1021\/acs.nanolett.4c01458","article-title":"Helper lipid-enhanced mRNA delivery for treating metabolic dysfunction-associated fatty liver disease","volume":"24","author":"Guo","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2026.124209_bib261","doi-asserted-by":"crossref","first-page":"34328","DOI":"10.1021\/acsami.2c05889","article-title":"Redox-unlockable nanoparticle-based MST1 delivery system to attenuate hepatic steatosis via the AMPK\/SREBP-1c signaling axis","volume":"14","author":"Li","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124209_bib262","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.2147\/IJN.S92162","article-title":"Natural product-based nanomedicine: recent advances and issues","author":"Xu","year":"2015","journal-title":"IJN"},{"key":"10.1016\/j.biomaterials.2026.124209_bib263","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1002\/fsn3.4178","article-title":"Polyphenols improve non\u2010alcoholic fatty liver disease via gut microbiota: a comprehensive review","volume":"12","author":"Mohammadhasani","year":"2024","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.biomaterials.2026.124209_bib264","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.4c10955","article-title":"Dynamic tracking of biological processes using near-infrared fluorescent single-walled carbon nanotubes","author":"Basu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124209_bib265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/1319-3767.96445","article-title":"Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches","volume":"18","author":"Ahmad","year":"2012","journal-title":"Saudi J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib266","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/954502","article-title":"Protective effect of astaxanthin on liver fibrosis through modulation of TGF- \u03b2 1 expression and autophagy","volume":"2014","author":"Shen","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biomaterials.2026.124209_bib267","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/13543776.2021.1896705","article-title":"Targeting the TGF-\u03b2 signaling pathway for fibrosis therapy: a patent review (2015\u20132020)","volume":"31","author":"Li","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biomaterials.2026.124209_bib268","article-title":"Biologically inspired, cell\u2010selective release of aptamer\u2010trapped growth factors by traction forces","volume":"31","author":"Stejskalov\u00e1","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib269","article-title":"Insights on drug and gene delivery systems in liver fibrosis","volume":"18","author":"Vyas","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/08982104.2012.727423","article-title":"Controlled drug-release system based on pH-sensitive chloride-triggerable liposomes","volume":"23","author":"Wehunt","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib271","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/ph15060708","article-title":"Focusing on future applications and current challenges of plant derived extracellular vesicles","volume":"15","author":"Wang","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biomaterials.2026.124209_bib272","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1039\/D4BM00812J","article-title":"Hemp sprout-derived exosome-like nanovesicles as hepatoprotective agents attenuate liver fibrosis","volume":"12","author":"Kim","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib273","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/acsnano.3c06107","article-title":"Antioxidative hyaluronic acid\u2013bilirubin nanomedicine targeting activated hepatic stellate cells for anti-hepatic-fibrosis therapy","volume":"18","author":"Shinn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124209_bib274","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201705673","article-title":"Recent advances in magnetic\u2010nanomaterial\u2010based mechanotransduction for cell fate regulation","volume":"30","author":"Wu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib275","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2217\/nnm.13.133","article-title":"Cerium oxide nanoparticles: applications and prospects in nanomedicine","volume":"8","author":"Das","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2026.124209_bib276","first-page":"1391","article-title":"RNA interference technology with emphasis on delivery vehicles\u2014prospects and limitations, artificial cells","volume":"44","author":"Prabha","year":"2016","journal-title":"Nanomedicine, and Biotechnology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib277","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1021\/acsnano.3c03217","article-title":"Nanoparticle-mediated RNA therapy attenuates nonalcoholic steatohepatitis and related fibrosis by targeting activated hepatic stellate cells","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124209_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111596","article-title":"Hydroxypropyl-\u03b2-cyclodextrin\/Oridonin and trehalose loaded nanovesicles attenuate foam cells formation and regulate the inflammation","volume":"180","author":"Li","year":"2022","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.biomaterials.2026.124209_bib279","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1021\/acs.molpharmaceut.4c00070","article-title":"Reactive Oxygen Species-Responsive Delivery of a Notch Inhibitor to Alleviate Nonalcoholic Steatohepatitis by Inhibiting Hepatic de Novo Lipogenesis and Inflammation","volume":"21","author":"Chen","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124209_bib280","doi-asserted-by":"crossref","first-page":"25080","DOI":"10.1021\/acsami.2c02354","article-title":"A ROS-responsive simvastatin nano-prodrug and its fibronectin-targeted Co-Delivery system for atherosclerosis treatment","volume":"14","author":"Zhao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124209_bib281","doi-asserted-by":"crossref","first-page":"58072","DOI":"10.1021\/acsami.4c13607","article-title":"Advanced applications of nanomaterials in atherosclerosis diagnosis and treatment: challenges and future prospects","volume":"16","author":"Tong","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124209_bib282","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429342447241214044859","article-title":"Aloperine alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation in macrophages and ApoE-\/- mice","volume":"17","author":"Wang","year":"2025","journal-title":"CMP"},{"key":"10.1016\/j.biomaterials.2026.124209_bib283","doi-asserted-by":"crossref","first-page":"996","DOI":"10.9734\/jabb\/2025\/v28i32157","article-title":"Nanomaterials in biomedical applications: a review","volume":"28","author":"Mohapatra","year":"2025","journal-title":"J. Adv. Biol. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib284","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900036","article-title":"Atherosclerosis treatment with stimuli\u2010responsive nanoagents: recent advances and future perspectives","volume":"8","author":"Maruf","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib285","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib286","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/cvr\/cvv237","article-title":"Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques","volume":"109","author":"Lewis","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib287","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/biology9030060","article-title":"Oxidative stress and antioxidants in atherosclerosis development and treatment","volume":"9","author":"Poznyak","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib288","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2147\/IJN.S53717","article-title":"Nanoparticles for multimodal in vivo imaging in nanomedicine","author":"Leary","year":"2014","journal-title":"IJN"},{"key":"10.1016\/j.biomaterials.2026.124209_bib289","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fbioe.2020.00200","article-title":"Antioxidant nanotherapies for the treatment of inflammatory diseases","volume":"8","author":"Li","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib290","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103357","article-title":"Potential nanocarrier-mediated miRNA-based therapy approaches for multiple sclerosis","volume":"27","author":"Trideva Sastri","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2026.124209_bib291","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/nano10091700","article-title":"Application of nanomaterials in biomedical imaging and cancer therapy","volume":"10","author":"Siddique","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biomaterials.2026.124209_bib292","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/wnan.72","article-title":"Multifunctional imaging nanoprobes","volume":"2","author":"Jarzyna","year":"2010","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"10.1016\/j.biomaterials.2026.124209_bib293","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7150\/thno.5658","article-title":"Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm","volume":"3","author":"Paulmurugan","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib294","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2217\/nnm.13.65","article-title":"Biomimetic self-assembling peptides as scaffolds for soft tissue engineering","volume":"8","author":"Maude","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2026.124209_bib295","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3748\/wjg.v24.i16.1679","article-title":"Beneficial effects of naringenin in liver diseases: molecular mechanisms","volume":"24","author":"Hern\u00e1ndez-Aquino","year":"2018","journal-title":"WJG"},{"key":"10.1016\/j.biomaterials.2026.124209_bib296","doi-asserted-by":"crossref","first-page":"385","DOI":"10.24976\/Discov.Med.202436181.36","article-title":"Artesunate inhibits lipid accumulation and inflammation by regulating the NLRP3 inflammasome in nonalcoholic fatty liver disease","volume":"36","author":"Sun","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib297","doi-asserted-by":"crossref","DOI":"10.15212\/bioi-2020-0040","article-title":"Nanocarriers in the enhancement of therapeutic efficacy of natural drugs","volume":"2","author":"Li","year":"2021","journal-title":"BIOI"},{"key":"10.1016\/j.biomaterials.2026.124209_bib298","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12951-024-02652-9","article-title":"Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation","volume":"22","author":"Luo","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib299","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102428","article-title":"Journey into tomorrow: cardiovascular wellbeing transformed by nano-scale innovations","volume":"49","author":"Safhi","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib300","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/gels8070423","article-title":"Research advances of injectable functional hydrogel materials in the treatment of myocardial infarction","volume":"8","author":"Hu","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.biomaterials.2026.124209_bib301","doi-asserted-by":"crossref","first-page":"454","DOI":"10.30629\/0023-2149-2023-101-9-10-454-466","article-title":"Nanoparticles for targeted drug delivery in modern cardiology","volume":"101","author":"Kidenko","year":"2023","journal-title":"Jour"},{"key":"10.1016\/j.biomaterials.2026.124209_bib302","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fbioe.2020.00323","article-title":"Combining nanomaterials and developmental pathways to design new treatments for cardiac regeneration: the pulsing heart of advanced therapies","volume":"8","author":"Cassani","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib303","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.7150\/thno.99961","article-title":"Nanomedicines as guardians of the heart: unleashing the power of antioxidants to alleviate myocardial ischemic injury","volume":"14","author":"Han","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib304","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1586\/erc.12.99","article-title":"Biomaterial applications in cardiovascular tissue repair and regeneration","volume":"10","author":"Lam","year":"2012","journal-title":"Expet Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.biomaterials.2026.124209_bib305","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/pharmaceutics14040758","article-title":"Designer functional nanomedicine for myocardial repair by regulating the inflammatory microenvironment","volume":"14","author":"Liu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib306","doi-asserted-by":"crossref","DOI":"10.37175\/stemedicine.v4i2.169","article-title":"Application of conductive hydrogels in cardiac tissue engineering","volume":"4","author":"Ren","year":"2023","journal-title":"STEMedicine"},{"key":"10.1016\/j.biomaterials.2026.124209_bib307","doi-asserted-by":"crossref","DOI":"10.1016\/j.cobme.2023.100474","article-title":"Intelligent biomaterials for cardiovascular applications","volume":"28","author":"Tetali","year":"2023","journal-title":"Current Opinion in Biomedical Engineering"},{"key":"10.1016\/j.biomaterials.2026.124209_bib308","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1021\/acs.inorgchem.4c00169","article-title":"Quantitative fluorescent lateral flow strip sensor for myocardial infarction using purity-color upconversion nanoparticles","volume":"63","author":"Li","year":"2024","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.biomaterials.2026.124209_bib309","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/molecules21060807","article-title":"Natural products to counteract the epidemic of cardiovascular and metabolic disorders","volume":"21","author":"Waltenberger","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2026.124209_bib310","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2174\/1389200217666160229113629","article-title":"Emerging potential of natural products as an alternative strategy to pharmacological agents used against metabolic disorders","volume":"17","author":"Dias","year":"2016","journal-title":"CDM"},{"key":"10.1016\/j.biomaterials.2026.124209_bib311","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.67428","article-title":"A comprehensive review of metabolic syndrome and its role in cardiovascular disease and type 2 diabetes mellitus: mechanisms, risk factors, and management","author":"Dhondge","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.biomaterials.2026.124209_bib312","series-title":"Mitochondrial Dynamics in Cardiovascular Medicine","first-page":"277","article-title":"Mitochondria in structural and functional cardiac remodeling","author":"Torrealba","year":"2017"},{"key":"10.1016\/j.biomaterials.2026.124209_bib313","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.109816","article-title":"Iron-rich air pollution nanoparticles: an unrecognised environmental risk factor for myocardial mitochondrial dysfunction and cardiac oxidative stress","volume":"188","author":"Maher","year":"2020","journal-title":"Environ. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib314","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117523","article-title":"Metabolic dysfunction-associated steatotic liver disease: an opportunity for collaboration between cardiology and hepatology","volume":"392","author":"Raggi","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biomaterials.2026.124209_bib315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOL.0000000000000673","article-title":"Novel lecithin:cholesterol acyltransferase-based therapeutic approaches","volume":"31","author":"Freeman","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib316","doi-asserted-by":"crossref","DOI":"10.1161\/atvb.33.suppl_1.A450","article-title":"Abstract 450: effects of multiple infusions of recombinant LCAT on plasma and tissue lipids and expression of genes involved in atherogenesis","volume":"33","author":"Vaisman","year":"2013","journal-title":"ATVB"},{"key":"10.1016\/j.biomaterials.2026.124209_bib317","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/hc4501.098468","article-title":"Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II","volume":"104","author":"Shah","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2026.124209_bib318","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/1061186X.2019.1641508","article-title":"Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents","volume":"28","author":"Lin","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2026.124209_bib319","article-title":"Farnesoid-X receptor (FXR) as a promising pharmaceutical target in atherosclerosis","volume":"24","author":"Moris","year":"2017","journal-title":"Comput. Mater. Continua (CMC)"},{"key":"10.1016\/j.biomaterials.2026.124209_bib320","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jccs.202400179","article-title":"Engineered metal nanoparticles for precision drug delivery: pioneering the future of medicine: mini review","volume":"71","author":"Ullah","year":"2024","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124209_bib321","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/1744666X.2021.1935877","article-title":"The pathogenic oral\u2013gut\u2013liver axis: new understandings and clinical implications","volume":"17","author":"Imai","year":"2021","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib322","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.livres.2020.03.002","article-title":"Intestinal barrier function and metabolic\/liver diseases","volume":"4","author":"Ghosh","year":"2020","journal-title":"Liver Research"},{"key":"10.1016\/j.biomaterials.2026.124209_bib323","doi-asserted-by":"crossref","DOI":"10.1016\/j.device.2023.100053","article-title":"Theranostic gastrointestinal residence systems","volume":"1","author":"Ying","year":"2023","journal-title":"Device"},{"key":"10.1016\/j.biomaterials.2026.124209_bib324","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202000196","article-title":"VCAM\u20101\u2010Targeted gene delivery nanoparticles localize to inflamed endothelial cells and atherosclerotic plaques","volume":"4","author":"Distasio","year":"2021","journal-title":"Adv. Therapeut."},{"key":"10.1016\/j.biomaterials.2026.124209_bib325","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.apsb.2024.05.008","article-title":"Current status and trends in small nucleic acid drug development: leading the future","volume":"14","author":"Miao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124209_bib326","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3389\/fphys.2018.00953","article-title":"RNA therapeutics in cardiovascular precision medicine","volume":"9","author":"Laina","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib327","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1039\/D0TB01499K","article-title":"Exosome: a significant nano-scale drug delivery carrier","volume":"8","author":"Peng","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biomaterials.2026.124209_bib328","first-page":"3715","article-title":"Liver-derived exosomes and their implications in liver pathobiology","volume":"19","author":"Sung","year":"2018","journal-title":"Indian J. Manag. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib329","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","article-title":"Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes","volume":"18","author":"Choi","year":"2021","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.biomaterials.2026.124209_bib330","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113835","article-title":"Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)","volume":"176","author":"Ke","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib331","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jcmm.16123","article-title":"Advances on liver cell\u2010derived exosomes in liver diseases","volume":"25","author":"Jiao","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib332","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.586130","article-title":"Recent advancements in the loading and modification of therapeutic exosomes","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib333","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jcp.30699","article-title":"The role of exosomal miRNA in nonalcoholic fatty liver disease","volume":"237","author":"Mahmoudi","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib334","article-title":"Exosome biochemistry and advanced nanotechnology for next\u2010generation Theranostic platforms","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib335","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/metabo13040479","article-title":"Exosomes in cardiovascular disease: from mechanism to therapeutic target","volume":"13","author":"Reiss","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.biomaterials.2026.124209_bib336","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bcp.2014.08.015","article-title":"Pharmacological potential of bioactive engineered nanomaterials","volume":"92","author":"Caputo","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib337","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1119005","article-title":"The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease","volume":"10","author":"Qin","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib338","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","article-title":"Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction","volume":"1261","author":"Silverman","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib339","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202421512","article-title":"Microenvironments\u2010targeted nanomaterials for atherosclerosis therapy","volume":"35","author":"Song","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib340","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/1061186X.2018.1437919","article-title":"Organ-based drug delivery","volume":"26","author":"Alsaggar","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2026.124209_bib341","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1039\/C9CS00309F","article-title":"Nanoparticles' interactions with vasculature in diseases","volume":"48","author":"Tee","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib342","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tcb.2017.11.006","article-title":"Exploiting metabolic vulnerabilities of cancer with precision and accuracy","volume":"28","author":"Wolpaw","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib343","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1440-1681.12886","article-title":"Role of mitochondria and mitochondria\u2010targeted agents in non\u2010alcoholic fatty liver disease","volume":"45","author":"Ajith","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib344","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1631\/jzus.B2300854","article-title":"Ceria nanoparticles: biomedical applications and toxicity","volume":"25","author":"Fu","year":"2024","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.biomaterials.2026.124209_bib345","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25143159","article-title":"Potential toxicity of iron oxide magnetic nanoparticles: a review","volume":"25","author":"Malhotra","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2026.124209_bib346","doi-asserted-by":"crossref","DOI":"10.34133\/2021\/4189516","article-title":"The dynamic inflammatory tissue microenvironment: signality and disease therapy by biomaterials","volume":"2021","author":"Mata","year":"2021","journal-title":"Research"},{"key":"10.1016\/j.biomaterials.2026.124209_bib347","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.copbio.2021.07.024","article-title":"Applications of artificial intelligence to enzyme and pathway design for metabolic engineering","volume":"73","author":"Jang","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib348","unstructured":"Pioneering Biomedical Applications with Intelligent Engineering - Qu - 2025 - Small Methods - Wiley Online Library, (n.d.). https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/smtd.202501013 (accessed March 21, 2026)."},{"key":"10.1016\/j.biomaterials.2026.124209_bib349","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100041","article-title":"Two heads are better than one: unravelling the potential impact of artificial intelligence in nanotechnology","volume":"3","author":"Naik","year":"2024","journal-title":"Nano TransMed"},{"key":"10.1016\/j.biomaterials.2026.124209_bib350","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40820-024-01634-8","article-title":"Artificial intelligence-powered materials science","volume":"17","author":"Bai","year":"2025","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.biomaterials.2026.124209_bib351","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.tibtech.2022.01.005","article-title":"Smart materials: rational design in biosystems via artificial intelligence","volume":"40","author":"Sagdic","year":"2022","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib352","article-title":"AI-driven decoding of material dynamics: from machine learning potentials and interpretability to generative prediction","author":"Zhao","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib353","doi-asserted-by":"crossref","DOI":"10.1016\/j.crbiot.2024.100211","article-title":"Deciphering the gut microbiome: the revolution of artificial intelligence in microbiota analysis and intervention","volume":"7","author":"Abavisani","year":"2024","journal-title":"Current Research in Biotechnology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib354","first-page":"92","article-title":"Smart materials for smart healthcare\u2013 moving from sensors and actuators to self-sustained nanoenergy nanosystems","volume":"1","author":"Arab Hassani","year":"2020","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib355","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ac15b2","article-title":"A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine","volume":"16","author":"Hayat","year":"2021","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib356","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1021\/acssuschemeng.0c07453","article-title":"Prediction of nano\u2013bio interactions through convolutional neural network analysis of nanostructure images","volume":"8","author":"Yan","year":"2020","journal-title":"ACS Sustainable Chem. Eng."},{"key":"10.1016\/j.biomaterials.2026.124209_bib357","doi-asserted-by":"crossref","first-page":"C1003","DOI":"10.1152\/ajpcell.00232.2022","article-title":"Noncoding RNAs and RNA-binding proteins: emerging governors of liver physiology and metabolic diseases","volume":"323","author":"Sommerauer","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib358","first-page":"260","volume":"26","author":"Wang","year":"2025"},{"key":"10.1016\/j.biomaterials.2026.124209_bib359","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114194","article-title":"Artificial intelligence to bring nanomedicine to life","volume":"184","author":"Serov","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib360","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/omi.2022.0079","article-title":"Multi-omics and artificial intelligence-guided data integration in chronic liver disease: prospects and challenges for precision medicine","volume":"26","author":"Lin","year":"2022","journal-title":"OMICS A J. Integr. Biol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib361","doi-asserted-by":"crossref","first-page":"102359","DOI":"10.1016\/j.artmed.2022.102359","article-title":"Graph neural network modelling as a potentially effective method for predicting and analyzing procedures based on patients\u2019 diagnoses","volume":"131","author":"Diaz Ochoa","year":"2022","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib362","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/jbm.b.33953","article-title":"When epigenetics meets bioengineering\u2014A material characteristics and surface topography perspective","volume":"106","author":"Larsson","year":"2018","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib363","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41576-021-00383-3","article-title":"Theranostic cells: emerging clinical applications of synthetic biology","volume":"22","author":"McNerney","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biomaterials.2026.124209_bib364","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101589","article-title":"Plasticity and adaptation in neuromorphic biohybrid systems","volume":"23","author":"George","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.biomaterials.2026.124209_bib365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/med4.62","article-title":"Applications of artificial intelligence and machine learning in clinical medicine: what lies ahead","volume":"2","author":"Raj","year":"2024","journal-title":"Medicine Advances"},{"key":"10.1016\/j.biomaterials.2026.124209_bib366","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mib.2020.07.014","article-title":"Engineered bacteria to report gut function: technologies and implementation","volume":"59","author":"Tanna","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib367","series-title":"Advances in Applied Microbiology","first-page":"49","article-title":"Toward genome-based metabolic engineering in bacteria","author":"Oesterle","year":"2017"},{"key":"10.1016\/j.biomaterials.2026.124209_bib368","article-title":"Nanotechnologies for enhancing anti-tumor therapies","volume":"7","author":"Ning","year":"2022","journal-title":"Open"},{"key":"10.1016\/j.biomaterials.2026.124209_bib369","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1021\/acs.chemrev.2c00074","article-title":"Introduction: smart materials","volume":"122","author":"Yin","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124209_bib370","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98097-3","article-title":"Persistence of functional microbiota composition across generations","volume":"11","author":"Ramos","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124209_bib371","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202270061","article-title":"Harnessing the therapeutic potential of extracellular vesicles for biomedical applications using multifunctional magnetic nanomaterials","volume":"18","author":"Yang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124209_bib372","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.7150\/thno.55795","article-title":"Organ-organ communication: the liver's perspective","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124209_bib373","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122824","article-title":"Liver-based inter-organ communication: a disease perspective","volume":"351","author":"Luo","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124209_bib374","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.molmed.2013.07.004","article-title":"Comorbidity: a multidimensional approach","volume":"19","author":"Capobianco","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib375","doi-asserted-by":"crossref","DOI":"10.20517\/mtod.2024.34","article-title":"Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge","volume":"4","author":"Jamalinia","year":"2024","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.biomaterials.2026.124209_bib376","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/adma.201202080","article-title":"Materials for drug delivery: innovative solutions to address complex biological hurdles","volume":"24","author":"Mitragotri","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib377","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10295-018-2013-9","article-title":"Dynamic metabolic control: towards precision engineering of metabolism","volume":"45","author":"Liu","year":"2018","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib378","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00253-024-13180-9","article-title":"Does \u201call disease begin in the gut\u201d? The gut-organ cross talk in the microbiome","volume":"108","author":"Chaudhary","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib379","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.664","article-title":"The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside","volume":"5","author":"Shen","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.biomaterials.2026.124209_bib380","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/0115734129298520240812062841","article-title":"Analyzing the metabolic destiny of Potentilla discolor bge. Extract and its primary components in rat models","volume":"20","author":"Dang","year":"2024","journal-title":"CPA"},{"key":"10.1016\/j.biomaterials.2026.124209_bib381","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/14\/140201","article-title":"Power is nothing without control","volume":"23","author":"Demming","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biomaterials.2026.124209_bib382","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/jbm.b.34000","article-title":"Development of next generation cardiovascular therapeutics through bio\u2010assisted nanotechnology","volume":"106","author":"Lakshmanan","year":"2018","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.biomaterials.2026.124209_bib383","doi-asserted-by":"crossref","DOI":"10.20517\/mtod.2021.03","article-title":"Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?","author":"Lonardo","year":"2021","journal-title":"MTOD"},{"key":"10.1016\/j.biomaterials.2026.124209_bib384","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2017.11.004","article-title":"Transcription factors: time to deliver","volume":"269","author":"Ulasov","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124209_bib385","doi-asserted-by":"crossref","DOI":"10.1002\/aisy.202070042","article-title":"Artificial intelligence to power the future of materials science and engineering","volume":"2","author":"Sha","year":"2020","journal-title":"Adv. Intell. Syst."},{"key":"10.1016\/j.biomaterials.2026.124209_bib386","article-title":"Biohybrid design gets personal: new materials for patient\u2010specific therapy","volume":"32","author":"Raman","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib387","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s43066-022-00224-w","article-title":"Artificial intelligence in nonalcoholic fatty liver disease","volume":"12","author":"Mahzari","year":"2022","journal-title":"Egypt Liver Journal"},{"key":"10.1016\/j.biomaterials.2026.124209_bib388","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12967-020-02658-5","article-title":"Precision medicine in the era of artificial intelligence: implications in chronic disease management","volume":"18","author":"Subramanian","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124209_bib389","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/EJE-20-0065","article-title":"Management of endocrine disease: non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease","volume":"183","author":"Ruissen","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib390","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2026.124209_bib391","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","article-title":"Metabolic phenotyping in health and disease","volume":"134","author":"Holmes","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2026.124209_bib392","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymben.2015.06.011","article-title":"Precision metabolic engineering: the design of responsive, selective, and controllable metabolic systems","volume":"31","author":"McNerney","year":"2015","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biomaterials.2026.124209_bib393","doi-asserted-by":"crossref","DOI":"10.1088\/1468-6996\/11\/1\/010302","article-title":"Focus on nanobiomaterials and technologies for breakthrough in future medicine","volume":"11","author":"Miyahara","year":"2010","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124209_bib394","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/17425247.2022.2034784","article-title":"An update on cell-penetrating peptides with intracellular organelle targeting","volume":"19","author":"Cerrato","year":"2022","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2026.124209_bib395","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000341794","article-title":"Synthetic biology and personalized medicine","volume":"22","author":"Jain","year":"2013","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.biomaterials.2026.124209_bib396","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1093\/toxsci\/kfq372","article-title":"The new toxicology of sophisticated materials: nanotoxicology and beyond","volume":"120","author":"Maynard","year":"2011","journal-title":"Toxicol. Sci."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:30Z","timestamp":1793946450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226002334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":395,"alternative-id":["S0142961226002334"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124209","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced materials for non-alcoholic fatty liver disease and cardiovascular disease comorbidity therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124209"}}